Nutex Health (NASDAQ:NUTX) Hits New 1-Year High - Here's What Happened

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) shares hit a new 52-week high during trading on Tuesday . The company traded as high as $187.20 and last traded at $181.06, with a volume of 283744 shares traded. The stock had previously closed at $160.95.Analysts Set New Price TargetsSeveral research firms recently weighed in on NUTX. Maxim Group set a $205.00 price target on Nutex Health and gave the stock a "buy" rating in a research note on Tuesday, August 26th. Weiss Ratings reissued a "hold (c)" rating on shares of Nutex Health in a research note on Monday, December 1st. Finally, Wall Street Zen upgraded Nutex Health from a "buy" rating to a "strong-buy" rating in a report on Friday, November 28th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Nutex Health currently has an average rating of "Moderate Buy" and an average price target of $252.50.Read Our Latest Stock Report on Nutex HealthNutex Health Trading Up 12.5%The firm has a market capitalization of $1.28 billion, a PE ratio of 9.79 and a beta of -0.03. The firm has a 50 day simple moving average of $118.38 and a 200 day simple moving average of $111.96. The company has a current ratio of 3.20, a quick ratio of 3.18 and a debt-to-equity ratio of 0.67. Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings results on Tuesday, November 18th. The company reported $7.76 earnings per share for the quarter, topping the consensus estimate of ($5.43) by $13.19. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.The firm had revenue of $243.99 million during the quarter, compared to analysts' expectations of $221.93 million. Insider ActivityIn related news, CFO Jon Christian Bates purchased 750 shares of Nutex Health stock in a transaction dated Tuesday, November 25th. The stock was purchased at an average cost of $136.71 per share, for a total transaction of $102,532.50. Following the completion of the purchase, the chief financial officer directly owned 5,638 shares of the company's stock, valued at $770,770.98. The trade was a 15.34% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 36.92% of the stock is currently owned by insiders. Institutional Investors Weigh In On Nutex HealthInstitutional investors and hedge funds have recently added to or reduced their stakes in the stock. Bank of America Corp DE raised its stake in Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after buying an additional 2,043 shares during the last quarter. Informed Momentum Co LLC purchased a new stake in Nutex Health during the first quarter valued at $868,000. American Century Companies Inc. lifted its holdings in Nutex Health by 73.0% in the first quarter. American Century Companies Inc. now owns 74,359 shares of the company's stock valued at $3,497,000 after acquiring an additional 31,366 shares during the period. OMERS ADMINISTRATION Corp boosted its position in Nutex Health by 28.8% in the first quarter. OMERS ADMINISTRATION Corp now owns 9,400 shares of the company's stock worth $442,000 after purchasing an additional 2,100 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in Nutex Health by 17.9% in the first quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company's stock worth $852,000 after purchasing an additional 2,748 shares during the last quarter. Hedge funds and other institutional investors own 5.32% of the company's stock. Nutex Health Company Profile (Get Free Report)Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.Featured ArticlesFive stocks we like better than Nutex HealthStock Average Calculator What Dollar Tree’s Surge and Home Depot’s Slide Say About Consumer HealthThe Significance of a Trillion-Dollar Market Cap Goes Beyond a Number3 Stocks Most Likely to Split in 2026What is Forex and How Does it Work? ChargePoint's Comeback Story: Why This EV Stock Is Charging Up AgainThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Nutex Health Right Now?Before you consider Nutex Health, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.While Nutex Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here